Fuse Biotherapeutics Funding & Investors

Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that spare healthy tissues. Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA.